Go Pro

IonQ (IONQ) Financials

IonQ logo
$46.35 +1.37 (+3.04%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$46.24 -0.11 (-0.24%)
As of 08/14/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for IonQ

Annual Income Statements for IonQ

This table shows IonQ's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-15 -106 -49 -158 -332 -510
Consolidated Net Income / (Loss)
-15 -106 -49 -158 -332 -512
Net Income / (Loss) Continuing Operations
-15 -106 -49 -158 -332 -512
Total Pre-Tax Income
-15 -106 -49 -158 -332 -557
Total Operating Income
-16 -39 -86 -158 -232 -634
Total Gross Profit
0.00 2.10 11 14 22 130
Total Revenue
0.00 2.10 11 22 43 130
Operating Revenue
0.00 2.10 11 22 43 130
Total Cost of Revenue
0.00 0.00 0.00 8.11 21 0.00
Total Operating Expenses
16 41 97 172 255 764
Selling, General & Admin Expense
3.55 14 36 51 71 245
Marketing Expense
0.49 3.23 8.39 18 28 53
Research & Development Expense
10 20 44 92 137 306
Depreciation Expense
1.40 2.55 5.60 10 19 82
Other Operating Expenses / (Income)
0.14 1.04 2.94 - - 77
Total Other Income / (Expense), net
0.31 -67 37 0.03 -99 77
Interest Expense
- -0.06 - -19 -18 -56
Other Income / (Expense), net
0.31 -68 30 -19 -117 21
Income Tax Expense
0.00 0.00 0.00 0.05 0.06 -45
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - 0.00 0.00 -1.74
Basic Earnings per Share
($0.13) ($0.77) ($0.25) ($0.78) ($1.56) ($1.82)
Weighted Average Basic Shares Outstanding
115.05M 137.61M 197.73M 202.58M 213.03M 280.35M
Diluted Earnings per Share
($0.13) ($0.77) ($0.25) ($0.78) ($1.56) ($1.82)
Weighted Average Diluted Shares Outstanding
115.05M 137.61M 197.73M 202.58M 213.03M 280.35M
Weighted Average Basic & Diluted Shares Outstanding
115.05M 137.61M 201.55M 208.23M 222.84M 366.64M

Quarterly Income Statements for IonQ

This table shows IonQ's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-42 -40 -38 -52 -202 -32 -177 -1,055 754 805 -1,868
Consolidated Net Income / (Loss)
-42 -40 -38 -52 -202 -32 -178 -1,056 753 805 -1,869
Net Income / (Loss) Continuing Operations
-42 -40 -38 -52 -202 -32 -178 -1,056 753 805 -1,869
Total Pre-Tax Income
-42 -40 -38 -52 -202 -32 -193 -1,060 728 798 -1,875
Total Operating Income
-54 -53 -49 -53 -78 -76 -161 -169 -229 -272 -337
Total Gross Profit
6.11 7.58 11 5.89 12 3.25 21 19 83 15 20
Total Revenue
6.11 7.58 11 12 12 7.57 21 40 62 65 80
Operating Revenue
6.11 7.58 11 12 12 7.57 21 40 62 65 80
Total Cost of Revenue
- 0.00 0.00 6.52 - 4.32 0.00 21 -21 49 60
Operating Cost of Revenue
- - - 6.52 - 4.32 - 21 - 49 60
Total Operating Expenses
61 60 60 59 89 79 181 187 312 287 357
Selling, General & Admin Expense
15 14 13 14 30 24 48 83 91 89 118
Marketing Expense
6.98 6.70 6.14 6.63 8.93 8.61 11 14 20 29 33
Research & Development Expense
32 32 31 33 40 40 103 66 96 126 161
Depreciation Expense
3.51 3.96 4.31 4.89 5.50 6.56 11 24 41 43 46
Total Other Income / (Expense), net
13 13 11 0.66 -124 43 -32 -891 957 1,070 -1,537
Interest Expense
- - -4.80 -4.51 - -4.89 -7.14 -14 - -28 -32
Other Income / (Expense), net
7.35 8.49 6.59 -3.85 -129 39 -39 -906 927 1,042 -1,569
Income Tax Expense
0.01 0.01 0.02 0.02 0.02 0.01 -15 -4.44 -25 -6.38 -6.07
Net Income / (Loss) Attributable to Noncontrolling Interest
- - 0.00 0.00 - 0.00 -0.69 -0.66 - -0.75 -0.86
Basic Earnings per Share
($0.20) ($0.19) ($0.18) ($0.24) ($0.95) ($0.14) ($0.70) ($3.58) $2.60 $2.19 ($5.08)
Weighted Average Basic Shares Outstanding
202.58M 208.16M 211.64M 214.31M 213.03M 228.76M 250.97M 294.52M 280.35M 358.82M 367.66M
Diluted Earnings per Share
($0.20) ($0.19) ($0.18) ($0.24) ($0.95) ($0.14) ($0.70) ($3.58) $2.60 $2.07 ($5.08)
Weighted Average Diluted Shares Outstanding
202.58M 208.16M 211.64M 214.31M 213.03M 228.76M 250.97M 294.52M 280.35M 371.23M 367.66M
Weighted Average Basic & Diluted Shares Outstanding
208.23M 211.45M 214.08M 216.39M 222.84M 247.78M 296.84M 354.28M 366.64M 373.27M 381.00M

Annual Cash Flow Statements for IonQ

This table details how cash moves in and out of IonQ's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-23 363 -353 -8.29 19 981
Net Cash From Operating Activities
-12 -27 -45 -79 -106 -283
Net Cash From Continuing Operating Activities
-12 -27 -45 -79 -106 -283
Net Income / (Loss) Continuing Operations
-15 -106 -49 -158 -332 -512
Consolidated Net Income / (Loss)
-15 -106 -49 -158 -332 -512
Depreciation Expense
1.40 2.55 5.60 10 19 82
Amortization Expense
0.04 0.53 -1.58 -9.75 -8.80 -8.32
Non-Cash Adjustments To Reconcile Net Income
1.30 77 2.28 91 229 309
Changes in Operating Assets and Liabilities, net
0.68 -0.20 -2.50 -13 -13 -154
Net Cash From Investing Activities
-12 -214 -309 69 83 -2,095
Net Cash From Continuing Investing Activities
-12 -214 -309 69 83 -2,095
Purchase of Property, Plant & Equipment
-11 -9.40 -12 -14 -18 -16
Acquisitions
-0.51 -0.62 -1.90 0.00 -15 0.52
Purchase of Investments
0.00 -204 -606 -298 -296 -2,758
Sale and/or Maturity of Investments
- 0.00 310 387 418 683
Other Investing Activities, net
- - - -5.85 -5.58 -4.22
Net Cash From Financing Activities
0.28 603 1.10 1.76 42 3,359
Net Cash From Continuing Financing Activities
0.28 603 1.10 1.76 42 3,359
Repayment of Debt
- - 0.02 -0.23 0.24 7.88
Repurchase of Preferred Equity
0.00 -0.97 0.00 0.00 0.00 0.00
Issuance of Common Equity
- - - 0.00 0.00 3,313
Other Financing Activities, net
0.28 604 1.08 1.99 41 38
Effect of Exchange Rate Changes
- - 0.00 -0.00 0.03 0.58

Quarterly Cash Flow Statements for IonQ

This table details how cash moves in and out of IonQ's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
-1.47 24 -18 -12 24 106 -19 209 685 -536 743
Net Cash From Operating Activities
-27 -20 -27 -19 -39 -33 -53 -123 -75 -151 -104
Net Cash From Continuing Operating Activities
-27 -20 -27 -19 -39 -33 -53 -123 -75 -151 -104
Net Income / (Loss) Continuing Operations
-42 -40 -38 -52 -202 -32 -178 -1,056 753 805 -1,869
Consolidated Net Income / (Loss)
-42 -40 -38 -52 -202 -32 -178 -1,056 753 805 -1,869
Depreciation Expense
3.51 3.96 4.31 4.89 5.50 6.56 11 24 41 43 46
Non-Cash Adjustments To Reconcile Net Income
24 14 16 31 169 -5.83 139 959 -785 -921 1,720
Changes in Operating Assets and Liabilities, net
-9.95 3.10 -6.40 0.12 -10 -1.51 -23 -48 -82 -78 -0.84
Net Cash From Investing Activities
24 44 8.30 6.54 24 -230 29 -673 -1,221 -392 834
Net Cash From Continuing Investing Activities
24 44 8.30 6.54 24 -230 29 -673 -1,221 -393 836
Purchase of Property, Plant & Equipment
-8.58 -4.54 -8.22 -4.71 -4.43 -2.31 -2.05 -5.20 -5.83 -10 -8.58
Acquisitions
-0.23 -0.36 -0.54 -0.31 -16 0.00 29 -41 14 -33 1.49
Purchase of Investments
-68 -67 -79 -95 -55 -321 -115 -817 -1,505 -641 -28
Sale and/or Maturity of Investments
101 115 97 107 100 94 117 197 275 292 872
Other Investing Activities, net
- - - - - -1.10 - - 1.08 -1.43 -1.13
Net Cash From Financing Activities
0.98 1.36 -0.03 1.09 39 369 4.12 1,005 1,981 6.90 12
Net Cash From Continuing Financing Activities
0.98 1.36 -0.03 1.09 39 369 4.12 1,005 1,981 6.90 12
Repayment of Debt
-0.24 0.00 - 0.00 0.09 0.52 - 0.99 6.90 1.54 -5.00
Other Financing Activities, net
1.22 1.36 -0.17 1.09 39 5.92 8.17 3.57 20 5.36 17

Annual Balance Sheets for IonQ

This table presents IonQ's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
60 642 598 554 508 6,570
Total Current Assets
39 530 372 390 379 2,586
Cash & Equivalents
36 399 44 36 54 1,031
Short-Term Investments
- 123 311 320 286 1,361
Accounts Receivable
0.39 0.71 3.29 11 10 67
Prepaid Expenses
2.07 6.44 13 23 28 128
Plant, Property, & Equipment, net
12 19 26 38 53 120
Total Noncurrent Assets
9.91 94 200 126 77 3,864
Long-Term Investments
- 80 182 100 24 945
Goodwill
- 0.00 0.74 0.74 9.90 1,964
Intangible Assets
2.69 5.84 8.94 15 29 767
Other Noncurrent Operating Assets
7.22 7.59 8.66 9.77 14 188
Total Liabilities & Shareholders' Equity
60 642 598 554 508 6,570
Total Liabilities
6.78 51 30 69 125 2,757
Total Current Liabilities
1.88 9.69 20 37 36 167
Accounts Payable
0.54 1.88 3.06 5.60 5.23 26
Accrued Expenses
0.61 2.65 6.66 18 17 90
Current Deferred Revenue
0.24 3.43 8.73 12 11 42
Other Current Liabilities
0.50 1.73 1.72 1.10 3.37 8.85
Total Noncurrent Liabilities
4.89 41 9.62 31 88 2,590
Noncurrent Deferred Revenue
1.12 1.53 1.20 0.45 0.00 1.92
Other Noncurrent Operating Liabilities
3.78 40 8.42 31 88 2,588
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
54 591 568 485 384 3,814
Total Preferred & Common Equity
54 591 568 485 384 3,800
Total Common Equity
54 591 568 485 384 3,800
Common Stock
93 737 770 839 1,067 5,006
Retained Earnings
-40 -146 -194 -352 -684 -1,194
Accumulated Other Comprehensive Income / (Loss)
- -0.15 -7.36 -1.97 0.16 -13
Noncontrolling Interest
- - - - 0.00 14

Quarterly Balance Sheets for IonQ

This table presents IonQ's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
588 577 565 544 517 498 850 1,347 4,319 6,694 6,779
Total Current Assets
402 391 404 410 405 395 637 626 1,215 2,303 2,410
Cash & Equivalents
52 14 37 60 42 30 160 140 346 494 1,236
Short-Term Investments
336 362 347 315 328 336 429 407 736 1,540 883
Accounts Receivable
1.84 2.43 3.03 9.56 7.89 4.14 9.47 19 37 98 106
Prepaid Expenses
13 13 17 25 27 26 39 60 96 171 185
Plant, Property, & Equipment, net
26 29 35 42 48 49 52 59 120 132 144
Total Noncurrent Assets
159 156 126 92 65 53 161 662 2,984 4,258 4,225
Long-Term Investments
138 134 101 59 32 17 109 110 403 1,058 840
Goodwill
0.74 0.74 0.74 0.73 0.72 0.73 11 371 1,866 2,128 2,186
Intangible Assets
10 12 13 17 17 17 28 143 656 781 779
Other Noncurrent Operating Assets
11 11 11 15 15 18 14 38 60 291 419
Total Liabilities & Shareholders' Equity
588 577 565 544 517 498 850 1,347 4,319 6,694 6,779
Total Liabilities
36 54 67 64 54 62 85 168 2,032 1,704 3,439
Total Current Liabilities
21 24 29 35 31 32 48 81 139 164 226
Accounts Payable
3.60 4.56 6.41 5.85 6.32 4.85 8.75 8.94 17 38 45
Accrued Expenses
9.41 9.25 16 11 8.93 16 24 49 92 65 97
Current Deferred Revenue
6.29 8.43 5.22 17 14 8.33 12 17 22 51 73
Other Current Liabilities
1.56 1.39 1.27 1.57 1.87 3.48 3.97 5.53 8.60 9.17 12
Total Noncurrent Liabilities
15 30 38 29 23 30 37 88 1,892 1,540 3,213
Noncurrent Deferred Revenue
0.95 0.71 0.46 0.18 0.12 0.06 0.00 2.77 3.38 13 14
Other Noncurrent Operating Liabilities
14 29 38 29 23 30 37 85 1,889 1,527 3,199
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
552 523 498 480 463 436 765 1,178 2,288 4,990 3,340
Total Preferred & Common Equity
552 523 498 480 463 436 765 1,162 2,273 4,976 3,327
Total Common Equity
552 523 498 480 463 436 765 1,162 2,273 4,976 3,327
Common Stock
779 795 813 873 894 917 1,481 2,050 4,238 5,420 5,638
Retained Earnings
-222 -265 -310 -392 -429 -482 -716 -893 -1,948 -389 -2,256
Accumulated Other Comprehensive Income / (Loss)
-5.43 -6.09 -4.79 -1.72 -1.32 0.34 -0.01 4.07 -17 -55 -54
Noncontrolling Interest
- - - - - - - 17 14 14 12

Annual Metrics And Ratios for IonQ

This table displays calculated financial ratios and metrics derived from IonQ's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - -
Revenue Growth
0.00% 0.00% 430.30% 98.02% 95.41% 201.85%
EBITDA Growth
0.00% -637.69% 50.01% -242.04% -92.72% -58.54%
EBIT Growth
0.00% -588.86% 47.67% -218.40% -97.60% -75.14%
NOPAT Growth
0.00% -145.90% -121.64% -83.98% -47.35% -172.62%
Net Income Growth
0.00% -588.45% 54.32% -225.23% -110.21% -54.42%
EPS Growth
0.00% -492.31% 67.53% -212.00% -100.00% -16.67%
Operating Cash Flow Growth
0.00% -121.01% -68.44% -76.32% -34.10% -167.96%
Free Cash Flow Firm Growth
0.00% 0.00% -5,601.50% -7.17% -40.89% -485.93%
Invested Capital Growth
0.00% -164.54% 368.00% -4.44% -31.09% 2,281.13%
Revenue Q/Q Growth
0.00% 0.00% 24.06% 11.64% 14.96% 62.85%
EBITDA Q/Q Growth
0.00% 0.00% 49.81% -16.05% -85.07% 63.55%
EBIT Q/Q Growth
0.00% 0.00% 48.49% -16.66% -83.33% 59.63%
NOPAT Q/Q Growth
0.00% 0.00% -17.52% -24.29% -11.01% -31.32%
Net Income Q/Q Growth
0.00% 0.00% 53.33% -17.29% -93.32% 65.10%
EPS Q/Q Growth
0.00% 0.00% 62.12% -14.71% -92.59% 66.11%
Operating Cash Flow Q/Q Growth
0.00% -3.92% -29.67% -17.46% -13.78% -14.14%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% -32.38% 17.39% 17.22%
Invested Capital Q/Q Growth
0.00% 0.00% 53.27% 117.04% -62.10% -40.60%
Profitability Metrics
- - - - - -
Gross Margin
0.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
0.00% -4,915.39% -463.36% -800.36% -789.33% -414.57%
Operating Margin
0.00% -1,843.12% -770.34% -715.70% -539.68% -487.41%
EBIT Margin
0.00% -5,061.93% -499.54% -803.22% -812.20% -471.24%
Profit (Net Income) Margin
0.00% -5,058.89% -435.82% -715.77% -769.96% -393.89%
Tax Burden Percent
100.00% 100.00% 100.00% 100.03% 100.02% 91.99%
Interest Burden Percent
100.00% 99.94% 87.24% 89.09% 94.78% 90.86%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -868.67% -629.66% -371.33% -662.91% -178.54%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -843.90% -631.68% -361.80% -621.70% -174.84%
Return on Net Nonoperating Assets (RNNOA)
0.00% 835.74% 621.29% 341.37% 586.57% 154.14%
Return on Equity (ROE)
-28.72% -32.93% -8.37% -29.96% -76.34% -24.40%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% -334.67% -366.79% -626.10% -362.42%
Operating Return on Assets (OROA)
0.00% -30.25% -8.97% -30.75% -65.88% -17.31%
Return on Assets (ROA)
0.00% -30.23% -7.82% -27.40% -62.46% -14.47%
Return on Common Equity (ROCE)
-28.72% -32.93% -8.37% -29.96% -76.34% -24.32%
Return on Equity Simple (ROE_SIMPLE)
-28.72% -17.96% -8.54% -32.53% -86.40% 0.00%
Net Operating Profit after Tax (NOPAT)
-11 -27 -60 -110 -163 -444
NOPAT Margin
0.00% -1,290.18% -539.23% -500.99% -377.77% -341.19%
Net Nonoperating Expense Percent (NNEP)
-12.21% -24.77% 2.02% -9.53% -41.21% -3.70%
Return On Investment Capital (ROIC_SIMPLE)
- - -10.56% -22.77% -42.39% -11.63%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 654.45% 323.12% 230.12% 164.96% 188.51%
R&D to Revenue
0.00% 963.70% 395.09% 418.84% 317.66% 235.13%
Operating Expenses to Revenue
0.00% 1,943.12% 870.34% 815.70% 639.68% 587.41%
Earnings before Interest and Taxes (EBIT)
-15 -106 -56 -177 -350 -613
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-14 -103 -52 -176 -340 -539
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 5.44 1.21 5.23 23.55 4.18
Price to Tangible Book Value (P/TBV)
0.00 5.49 1.24 5.41 26.24 14.88
Price to Revenue (P/Rev)
0.00 1,531.46 61.98 115.07 209.85 122.27
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 5.00 71.58 433.14 26.37
Enterprise Value to Revenue (EV/Rev)
0.00 1,244.38 13.66 94.38 201.40 96.71
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 1,411.79 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.67 -0.99 -0.98 -0.94 -0.94 -0.88
Leverage Ratio
1.13 1.09 1.07 1.09 1.22 1.69
Compound Leverage Factor
1.13 1.09 0.93 0.97 1.16 1.53
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.37%
Common Equity to Total Capital
99.99% 100.00% 100.00% 100.00% 100.00% 99.63%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 38.08 13.86 21.05 40.29 3.36
Noncontrolling Interest Sharing Ratio
0.01% 0.00% 0.00% 0.00% 0.00% 0.34%
Liquidity Ratios
- - - - - -
Current Ratio
20.51 54.65 18.43 10.49 10.50 15.50
Quick Ratio
19.41 53.99 17.81 9.87 9.71 14.74
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 1.85 -102 -109 -154 -900
Operating Cash Flow to CapEx
-107.56% -282.19% -388.17% -431.58% -482.64% -1,724.96%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.01 0.02 0.04 0.08 0.04
Accounts Receivable Turnover
0.00 3.83 5.57 2.99 3.98 3.39
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.14 0.50 0.69 0.95 1.50
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 95.38 65.57 122.20 91.75 107.69
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 95.38 65.57 122.20 91.75 107.69
Capital & Investment Metrics
- - - - - -
Invested Capital
18 -11 30 29 20 477
Invested Capital Turnover
0.00 0.67 1.17 0.74 1.75 0.52
Increase / (Decrease) in Invested Capital
0.00 -29 42 -1.35 -9.04 457
Enterprise Value (EV)
0.00 2,612 152 2,080 8,675 12,574
Market Capitalization
0.00 3,215 690 2,536 9,039 15,897
Book Value per Share
$1.42 $3.07 $2.84 $2.37 $1.77 $10.72
Tangible Book Value per Share
$1.35 $3.04 $2.79 $2.29 $1.59 $3.02
Total Capital
54 591 568 485 384 3,814
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-36 -603 -538 -456 -364 -3,337
Capital Expenditures (CapEx)
11 9.40 12 18 22 16
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.58 -2.54 -4.33 -2.62 2.43 27
Debt-free Net Working Capital (DFNWC)
37 520 351 353 343 2,420
Net Working Capital (NWC)
37 520 351 353 343 2,420
Net Nonoperating Expense (NNE)
4.41 79 -12 47 169 69
Net Nonoperating Obligations (NNO)
-36 -603 -538 -456 -364 -3,337
Total Depreciation and Amortization (D&A)
1.44 3.08 4.03 0.63 9.85 74
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -121.11% -38.89% -11.87% 5.64% 21.12%
Debt-free Net Working Capital to Revenue
0.00% 24,770.18% 3,157.56% 1,600.69% 795.67% 1,861.01%
Net Working Capital to Revenue
0.00% 24,770.18% 3,157.56% 1,600.69% 795.67% 1,861.01%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 ($0.77) ($0.25) ($0.78) ($1.56) ($1.82)
Adjusted Weighted Average Basic Shares Outstanding
0.00 197.67M 197.73M 202.58M 213.03M 280.35M
Adjusted Diluted Earnings per Share
$0.00 ($0.77) ($0.25) ($0.78) ($1.56) ($1.82)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 197.67M 197.73M 202.58M 213.03M 280.35M
Adjusted Basic & Diluted Earnings per Share
$0.00 ($0.77) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 137.61M 201.55M 208.23M 222.84M 366.64M
Normalized Net Operating Profit after Tax (NOPAT)
-11 -27 -60 -110 -163 -444
Normalized NOPAT Margin
0.00% -1,290.18% -539.23% -500.99% -377.77% -341.19%
Pre Tax Income Margin
0.00% -5,058.89% -435.82% -715.56% -769.83% -428.17%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for IonQ

This table displays calculated financial ratios and metrics derived from IonQ's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 366,640,756.00 373,269,948.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 366,640,756.00 373,269,948.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 2.20 -5.00
Growth Metrics
- - - - - - - - - - -
Revenue Growth
60.39% 76.94% 106.36% 102.09% 91.78% -0.21% 81.83% 221.50% 428.52% 754.72% 286.83%
EBITDA Growth
-112.71% -34.82% 17.20% -9.40% -339.33% 25.15% -372.41% -1,835.64% 464.43% 2,759.61% -882.75%
EBIT Growth
-115.93% -40.59% 12.86% -14.48% -337.60% 16.33% -372.14% -1,785.46% 439.06% 2,173.56% -853.62%
NOPAT Growth
-130.49% -88.69% -47.91% -25.93% -42.34% -43.13% -228.13% -217.71% -335.82% -416.61% -110.00%
Net Income Growth
-124.72% -44.82% 14.08% -17.15% -382.05% 18.54% -372.64% -1,910.84% 472.91% 2,594.76% -952.55%
EPS Growth
-100.00% -35.71% 18.18% -9.09% -375.00% 26.32% -288.89% -1,391.67% 373.68% 1,578.57% -625.71%
Operating Cash Flow Growth
-78.57% -48.14% -65.23% 13.77% -48.06% -61.37% -97.80% -540.66% -88.98% -357.30% -97.35%
Free Cash Flow Firm Growth
36.94% -29.57% -413.67% -232.03% -22.99% -35.83% -602.95% -1,032.69% -1,433.31% -2,684.46% 83.53%
Invested Capital Growth
-4.44% 69.62% 336.56% 294.61% -31.09% 49.80% 751.38% 1,419.30% 2,281.13% 2,694.96% -27.15%
Revenue Q/Q Growth
-0.49% 24.17% 50.11% 8.95% -5.56% -35.39% 173.51% 92.65% 55.25% 4.49% 23.79%
EBITDA Q/Q Growth
7.38% 7.22% 5.16% -34.22% -271.96% 84.19% -498.62% -449.97% 170.03% 10.28% -328.82%
EBIT Q/Q Growth
5.38% 5.77% 4.59% -34.57% -261.69% 81.98% -438.42% -437.41% 165.04% 10.18% -347.62%
NOPAT Q/Q Growth
-29.04% 2.89% 7.44% -8.57% -45.86% 2.35% -112.20% -5.12% -100.09% -15.75% 13.74%
Net Income Q/Q Growth
6.49% 5.52% 5.13% -39.76% -284.79% 84.03% -450.45% -494.61% 171.36% 6.82% -332.24%
EPS Q/Q Growth
9.09% 5.00% 5.26% -33.33% -295.83% 85.26% -400.00% -411.43% 172.63% -20.38% -345.41%
Operating Cash Flow Q/Q Growth
-19.52% 23.15% -29.88% 27.72% -105.24% 16.24% -59.19% -134.10% 39.46% -102.69% 31.30%
Free Cash Flow Firm Q/Q Growth
-59.27% -51.28% -46.57% 5.98% 41.01% -67.08% -658.54% -51.50% 20.14% -203.41% 95.51%
Invested Capital Q/Q Growth
117.04% 55.96% 35.25% -13.81% -62.10% 239.03% 668.69% 53.82% -40.60% 297.95% -79.96%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 46.69% 134.34% 23.84% 24.91%
EBITDA Margin
-754.26% -563.57% -356.09% -438.69% -1,727.87% -422.71% -925.16% -2,641.18% 1,191.40% 1,257.38% -2,324.25%
Operating Margin
-891.71% -697.39% -430.02% -428.51% -661.85% -1,000.25% -776.03% -423.45% -369.42% -419.85% -421.29%
EBIT Margin
-771.41% -585.37% -372.09% -459.58% -1,760.20% -490.80% -966.16% -2,695.25% 1,129.21% 1,190.69% -2,381.82%
Profit (Net Income) Margin
-686.28% -522.18% -330.03% -423.35% -1,725.00% -426.28% -857.88% -2,647.90% 1,217.12% 1,244.22% -2,334.29%
Tax Burden Percent
100.02% 100.02% 100.04% 100.03% 100.01% 100.04% 92.08% 99.58% 103.42% 100.80% 99.68%
Interest Burden Percent
88.95% 89.19% 88.66% 92.09% 97.99% 86.82% 96.43% 98.66% 104.23% 103.67% 98.32%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -3.42% -0.80% 0.00%
Return on Invested Capital (ROIC)
-462.65% -343.35% -249.33% -339.38% -812.99% -532.50% -97.55% -55.31% -199.91% -80.57% -161.13%
ROIC Less NNEP Spread (ROIC-NNEP)
-461.89% -342.82% -248.60% -335.85% -776.94% -536.16% -85.25% 45.07% -253.40% -137.49% -70.83%
Return on Net Nonoperating Assets (RNNOA)
435.81% 318.88% 229.61% 312.04% 733.04% 487.39% 54.96% -30.91% 223.40% 90.52% 56.69%
Return on Equity (ROE)
-26.85% -24.47% -19.71% -27.34% -79.94% -45.11% -42.59% -86.22% 23.49% 9.95% -104.44%
Cash Return on Invested Capital (CROIC)
-366.79% -406.45% -494.19% -561.75% -626.10% -355.48% -246.03% -254.26% -362.42% -286.30% -124.73%
Operating Return on Assets (OROA)
-29.53% -26.21% -21.22% -32.39% -142.79% -30.32% -54.29% -89.34% 41.48% 59.07% -144.50%
Return on Assets (ROA)
-26.27% -23.38% -18.82% -29.84% -139.93% -26.33% -48.20% -87.77% 44.71% 61.72% -141.62%
Return on Common Equity (ROCE)
-26.85% -24.47% -19.71% -27.34% -79.94% -45.11% -42.15% -85.76% 23.41% 9.93% -103.77%
Return on Equity Simple (ROE_SIMPLE)
0.00% -35.44% -35.37% -39.38% 0.00% -42.39% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-38 -37 -34 -37 -54 -53 -112 -118 -236 -274 -236
NOPAT Margin
-624.20% -488.17% -301.02% -299.96% -463.30% -700.18% -543.22% -296.42% -382.03% -423.20% -294.90%
Net Nonoperating Expense Percent (NNEP)
-0.76% -0.54% -0.72% -3.53% -36.05% 3.66% -12.30% -100.38% 53.49% 56.92% -90.30%
Return On Investment Capital (ROIC_SIMPLE)
-7.86% - - - -14.13% -6.92% -9.54% -5.17% -6.20% -5.48% -7.07%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 53.31% -34.34% 76.16% 75.09%
SG&A Expenses to Revenue
250.31% 184.91% 114.69% 115.50% 253.29% 314.64% 232.47% 206.96% 146.50% 137.03% 146.88%
R&D to Revenue
517.85% 426.91% 274.18% 267.56% 342.25% 528.06% 499.46% 166.30% 155.27% 194.44% 200.66%
Operating Expenses to Revenue
991.71% 797.39% 530.02% 528.51% 761.85% 1,100.25% 876.03% 470.14% 503.76% 443.68% 446.20%
Earnings before Interest and Taxes (EBIT)
-47 -44 -42 -57 -206 -37 -200 -1,074 699 770 -1,907
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-46 -43 -41 -54 -202 -32 -191 -1,053 737 813 -1,861
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.23 4.34 3.21 4.29 23.55 6.43 9.17 8.03 4.18 2.12 5.98
Price to Tangible Book Value (P/TBV)
5.41 4.50 3.34 4.48 26.24 6.77 16.44 0.00 14.88 5.11 54.86
Price to Revenue (P/Rev)
115.07 82.10 47.64 49.94 209.85 114.22 203.31 228.66 122.27 56.49 80.66
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 32.30 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.10% 0.00%
Enterprise Value to Invested Capital (EV/IC)
71.58 36.31 17.69 28.16 433.14 62.16 19.17 20.91 26.37 3.95 44.53
Enterprise Value to Revenue (EV/Rev)
94.38 64.95 34.76 39.72 201.40 98.03 191.09 210.24 96.71 40.04 68.70
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23.94 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 38.53 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.94 -0.93 -0.92 -0.93 -0.94 -0.91 -0.64 -0.69 -0.88 -0.66 -0.80
Leverage Ratio
1.09 1.10 1.11 1.14 1.22 1.12 1.14 1.77 1.69 1.31 1.80
Compound Leverage Factor
0.97 0.98 0.98 1.05 1.20 0.97 1.09 1.75 1.76 1.36 1.77
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.43% 0.63% 0.37% 0.28% 0.37%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 98.57% 99.37% 99.63% 99.72% 99.63%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
21.82 19.07 15.96 17.26 41.22 34.26 37.10 4.26 4.02 4.43 2.50
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.02% 0.53% 0.34% 0.24% 0.65%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
10.49 11.81 13.15 12.23 10.50 13.17 7.76 8.73 15.50 14.05 10.66
Quick Ratio
9.87 11.09 12.27 11.44 9.71 12.36 7.02 8.04 14.74 13.01 9.84
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-37 -56 -82 -77 -45 -76 -573 -868 -693 -2,104 -94
Operating Cash Flow to CapEx
-310.26% -450.77% -323.42% -408.31% -889.22% -988.18% -2,570.86% -2,365.97% -1,278.48% -1,509.49% -1,209.57%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.04 0.04 0.06 0.07 0.08 0.06 0.06 0.03 0.04 0.05 0.06
Accounts Receivable Turnover
2.99 4.45 6.05 10.45 3.98 4.53 3.88 3.89 3.39 3.48 3.94
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.69 0.74 0.81 0.88 0.95 0.92 0.98 0.94 1.50 2.03 2.43
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.35 0.00 1.91 3.93
Days Sales Outstanding (DSO)
122.20 82.06 60.36 34.92 91.75 80.65 94.11 93.84 107.69 105.01 92.57
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 270.25 0.00 191.11 92.97
Cash Conversion Cycle (CCC)
122.20 82.06 60.36 34.92 91.75 80.65 94.11 -176.41 107.69 -86.10 -0.39
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
29 45 61 53 20 68 522 803 477 1,898 380
Invested Capital Turnover
0.74 0.70 0.83 1.13 1.75 0.76 0.18 0.19 0.52 0.19 0.55
Increase / (Decrease) in Invested Capital
-1.35 19 47 39 -9.04 23 461 750 457 1,830 -142
Enterprise Value (EV)
2,080 1,646 1,085 1,488 8,675 4,221 10,007 16,785 12,574 7,492 16,933
Market Capitalization
2,536 2,080 1,487 1,871 9,039 4,918 10,647 18,256 15,897 10,570 19,880
Book Value per Share
$2.37 $2.30 $2.19 $2.04 $1.77 $3.43 $4.69 $7.66 $10.72 $13.57 $8.91
Tangible Book Value per Share
$2.29 $2.22 $2.11 $1.95 $1.59 $3.26 $2.61 ($0.84) $3.02 $5.64 $0.97
Total Capital
485 480 463 436 384 765 1,178 2,288 3,814 4,990 3,340
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-456 -434 -402 -383 -364 -697 -657 -1,485 -3,337 -3,092 -2,959
Capital Expenditures (CapEx)
8.58 4.54 8.22 4.71 4.43 3.34 2.05 5.20 5.83 10 8.58
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-2.62 -0.13 4.27 -2.63 2.43 0.32 -1.60 -6.34 27 106 65
Debt-free Net Working Capital (DFNWC)
353 375 374 363 343 589 545 1,076 2,420 2,139 2,184
Net Working Capital (NWC)
353 375 374 363 343 589 545 1,076 2,420 2,139 2,184
Net Nonoperating Expense (NNE)
3.79 2.58 3.30 15 148 -21 65 937 -990 -1,078 1,633
Net Nonoperating Obligations (NNO)
-456 -434 -402 -383 -364 -697 -657 -1,485 -3,337 -3,092 -2,959
Total Depreciation and Amortization (D&A)
1.05 1.65 1.82 2.59 3.79 5.15 8.49 22 38 43 46
Debt-free, Cash-free Net Working Capital to Revenue
-11.87% -0.50% 13.68% -7.03% 5.64% 0.74% -3.05% -7.95% 21.12% 56.41% 26.27%
Debt-free Net Working Capital to Revenue
1,600.69% 1,480.81% 1,198.74% 969.00% 795.67% 1,367.04% 1,041.16% 1,347.79% 1,861.01% 1,143.15% 885.99%
Net Working Capital to Revenue
1,600.69% 1,480.81% 1,198.74% 969.00% 795.67% 1,367.04% 1,041.16% 1,347.79% 1,861.01% 1,143.15% 885.99%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.20) ($0.19) ($0.18) ($0.24) ($0.95) ($0.14) ($0.70) ($3.58) $2.60 $2.19 ($5.08)
Adjusted Weighted Average Basic Shares Outstanding
202.58M 208.16M 211.64M 214.31M 213.03M 228.76M 250.97M 294.52M 280.35M 358.82M 367.66M
Adjusted Diluted Earnings per Share
($0.20) ($0.19) ($0.18) ($0.24) ($0.95) ($0.14) ($0.70) ($3.58) $2.60 $2.07 ($5.08)
Adjusted Weighted Average Diluted Shares Outstanding
202.58M 208.16M 211.64M 214.31M 213.03M 228.76M 250.97M 294.52M 280.35M 371.23M 367.66M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
208.23M 211.45M 214.08M 216.39M 222.84M 247.78M 296.84M 354.28M 366.64M 373.27M 381.00M
Normalized Net Operating Profit after Tax (NOPAT)
-38 -37 -34 -37 -54 -53 -112 -118 -160 -190 -236
Normalized NOPAT Margin
-624.20% -488.17% -301.02% -299.96% -463.30% -700.18% -543.22% -296.42% -258.59% -293.89% -294.90%
Pre Tax Income Margin
-686.13% -522.08% -329.90% -423.23% -1,724.83% -426.12% -931.67% -2,659.03% 1,176.92% 1,234.35% -2,341.87%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

IonQ’s latest quarter shows a mix of strong liquidity and continued operating losses, with a big swing in reported profitability driven by non-operating gains. In Q1 2026, the company generated $64.7 million of revenue versus $49.3 million of cost of revenue, producing $15.4 million of gross profit. However, operating expenses were far higher at $286.9 million, leaving an operating loss of $271.5 million.

The headline bottom line looks unusually strong, but investors should be careful. IonQ reported net income of $804.6 million in Q1 2026, largely because of $1.04 billion in “other income, net,” which overwhelmed the operating loss and interest expense. That means the quarter’s profitability was not driven by core operations.

Cash generation remains the key issue. IonQ used $151.0 million in operating cash in Q1 2026, compared with an operating cash outflow of $74.5 million in Q4 2025 and $123.1 million in Q3 2025. Over the last several quarters, the business has consistently burned cash from operations despite revenue growth.

On the positive side, the balance sheet is much stronger than it was a year ago. As of March 31, 2026, IonQ held $493.5 million in cash and equivalents plus $1.54 billion in short-term investments, along with $1.06 billion in long-term investments. Total current assets were $2.30 billion, while total liabilities were only $1.70 billion.

That gives the company a sizeable liquidity cushion. Current assets of $2.30 billion versus current liabilities of $163.9 million suggest near-term financial flexibility is solid, even though profitability is not yet self-sustaining.

Revenue continues to trend upward, but expenses are rising too. Quarterly revenue increased from $7.6 million in Q1 2024 to $64.7 million in Q1 2026, showing meaningful top-line growth over two years. At the same time, R&D and operating spending have expanded sharply as IonQ invests in growth and commercialization.

Share count dilution has been significant. Basic weighted average shares outstanding rose from about 208.2 million in Q1 2024 to 358.8 million in Q1 2026. That kind of dilution can weigh on per-share value even if the business continues to grow.

There are also some accounting and quality-of-earnings items worth noting. Goodwill on the balance sheet increased to $2.13 billion in Q1 2026, and intangible assets totaled $781.1 million. These non-cash assets are large relative to revenue and should be monitored for future impairment risk.

  • Cash, equivalents, and investments totaled roughly $3.1 billion at Q1 2026, giving IonQ substantial liquidity.
  • Revenue rose to $64.7 million in Q1 2026, well above the $7.6 million reported in Q1 2024.
  • Current assets of $2.30 billion far exceed current liabilities of $163.9 million.
  • The company reported positive net income in Q1 2026, though it was driven mainly by non-operating gains.
  • Other income, net was $1.04 billion in Q1 2026, making earnings quality a key point to watch.
  • Goodwill and intangible assets make up a large portion of the asset base.
  • Noncontrolling interest remains small and does not appear to be a major driver of results.
  • Operating cash flow was negative $151.0 million in Q1 2026.
  • Operating loss widened to $271.5 million in Q1 2026.
  • Share dilution has been substantial over the past year.

Bottom line: IonQ has the cash to keep investing, and revenue is clearly trending in the right direction, but the core business is still not profitable and is consuming cash. For retail investors, the main question is whether revenue growth can eventually outpace the company’s rapidly expanding expense base.

08/15/26 05:55 AM ETAI Generated. May Contain Errors.

IonQ Financials - Frequently Asked Questions

According to the most recent income statement we have on file, IonQ's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

IonQ's net income appears to be on an upward trend, with a most recent value of -$512.12 million in 2025, rising from -$15.42 million in 2020. The previous period was -$331.65 million in 2024. Check out IonQ's forecast to explore projected trends and price targets.

IonQ's total operating income in 2025 was -$633.72 million, based on the following breakdown:
  • Total Gross Profit: $130.02 million
  • Total Operating Expenses: $763.73 million

Over the last 5 years, IonQ's total revenue changed from $0.00 in 2020 to $130.02 million in 2025, a change of 13,001,600,000.0%.

IonQ's total liabilities were at $2.76 billion at the end of 2025, a 2,113.7% increase from 2024, and a 40,588.8% increase since 2020.

In the past 5 years, IonQ's cash and equivalents has ranged from $35.67 million in 2023 to $1.03 billion in 2025, and is currently $1.03 billion as of their latest financial filing in 2025.

Over the last 5 years, IonQ's book value per share changed from 1.42 in 2020 to 10.72 in 2025, a change of 657.0%.



Financial statements for NYSE:IONQ last updated on 8/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners